Health And Medicine

Craig Lindsley, William K. Warren, Jr. Chair in Medicine and university professor of chemistry, pharmacology and biochemistry, has been named editor in chief of the "Journal of Medicinal Chemistry." His appointment will begin Jan. 1.  Read More

Chancellor Daniel Diermeier will host a special presentation with coronavirus expert Dr. Mark R. Denison on Monday, Dec. 14, from 11 a.m. to noon Central time. Denison’s presentation, “Preparing for the COVID-19 Pandemic ... for 36 Years,” will explore why COVID-19 emerged, his lab’s discoveries, and where we go from here. Read More

David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods. Read More

Understanding the function of host cells when infected with SARS-CoV-2 may lead to host-directed antiviral therapeutics. Read More

The Vanderbilt School of Medicine Basic Sciences has won continued funding from the National Institutes of Health for its Initiative for Maximizing Student Diversity program supporting the success of biomedical graduate students from underrepresented backgrounds. Read More

Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology. Read More

When in-person research activities at Vanderbilt were put on hold in mid-March due to the COVID-19 pandemic, nursing professor Sheila Ridner’s steadfast commitment to patients ensured that their care did not suffer. Read More

Modernized endoscopic system blends robotics and magnetic coupling to improve medical procedures, starting with colonoscopies. Read More

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.  Read More

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. Read More

Further research by biochemistry professors Charles Sanders and  Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read More

Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus. Read More

Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read More

Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe. Read More

Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. Read More

A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. Read More

Vanderbilt University Medical Center health policy experts share what’s next for drug policy, insurance coverage, health care access and pandemic response in a free virtual discussion on Monday, Nov. 16. Read More

A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read More

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read More

Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics.  Read More